157 related articles for article (PubMed ID: 12647510)
1. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.
Shekelle P; Hardy ML; Morton SC; Maglione M; Suttorp M; Roth E; Jungvig L; Mojica WA; Gagné J; Rhodes S; McKinnon E
Evid Rep Technol Assess (Summ); 2003 Mar; (76):1-4. PubMed ID: 12647510
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
[TBL] [Abstract][Full Text] [Related]
3. Ephedra: once a boon, now a bane.
Scheindlin S
Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
[No Abstract] [Full Text] [Related]
4. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
[TBL] [Abstract][Full Text] [Related]
5. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
6. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
7. The need for regulation of dietary supplements--lessons from ephedra.
Fontanarosa PB; Rennie D; DeAngelis CD
JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
[No Abstract] [Full Text] [Related]
8. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
9. Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.
Miller SC
Mil Med; 2004 Feb; 169(2):87-93. PubMed ID: 15040625
[TBL] [Abstract][Full Text] [Related]
10. Legal ephedra?
Consum Rep; 2010 Mar; 75(3):11. PubMed ID: 20358659
[No Abstract] [Full Text] [Related]
11. Ergogenic aids: an update on ephedra.
Keisler BD; Hosey RG
Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
[TBL] [Abstract][Full Text] [Related]
12. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
13. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
14. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
15. Addressing the potential risks associated with ephedra use: a review of recent efforts.
Schulman S
Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905
[TBL] [Abstract][Full Text] [Related]
16. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
Gurley BJ; Steelman SC; Thomas SL
Clin Ther; 2015 Feb; 37(2):275-301. PubMed ID: 25262198
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of ephedra and ephedrine for enhancement of athletic performance, thermogenesis and the treatment of obesity.
Shekelle P; Hardy M
Phytomedicine; 2002 Jan; 9(1):78. PubMed ID: 11924769
[No Abstract] [Full Text] [Related]
18. Dietary supplements in weight reduction.
Dwyer JT; Allison DB; Coates PM
J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S80-6. PubMed ID: 15867902
[TBL] [Abstract][Full Text] [Related]
19. Medicolegal issues and ergogenic aids: trade, tragedy, and public safety, the example of ephedra and the Dietary Supplement Health and Education Act.
Phillips GC
Curr Sports Med Rep; 2004 Aug; 3(4):224-8. PubMed ID: 15231227
[TBL] [Abstract][Full Text] [Related]
20. Ephedrine alkaloids banned from dietary supplements.
Thompson CA
Am J Health Syst Pharm; 2004 Apr; 61(8):750-2, 756. PubMed ID: 15127956
[No Abstract] [Full Text] [Related]
[Next] [New Search]